Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sascha Gerdes

21PUBLICATIONS
53CO-AUTHORS
Counselling, wellbeing and community servicesProteins and peptidesEpidemiological modellingCounselling psychologyPanel data analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

Sort by Publication Date:
|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study.

|Apr 25, 2026
Could the IL-17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?

|Nov 28, 2025
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.

Luise Heinrich, Thomas Birkner, Susanne Abraham

|Aug 09, 2025
Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS Study.

Sascha Gerdes, Peter Weisenseel, Durdana Groß

|Jul 03, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study.

Ulrich Mrowietz, Rachel Sommer, Sascha Gerdes

|Apr 25, 2025
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA).

Diamant Thaçi, Sascha Gerdes, Hendrik Schulze-Koops

Pageof 4

Frequent Collaborators

4 joint publications

Ulrich Mrowietz

4 joint publications

Matthias Augustin

2 joint publications

Joerg Albrecht

2 joint publications

Elke M G J De Jong

2 joint publications

Rachel Sommer

2 joint publications

Y Personke

1 joint publications

P J Morrison

1 joint publications

Arnau Domenech

1 joint publications

E Dauden

1 joint publications

M Gooderham

Frequent Collaborators

4 joint publications

Ulrich Mrowietz

4 joint publications

Matthias Augustin

2 joint publications

Joerg Albrecht

2 joint publications

Elke M G J De Jong